252 related articles for article (PubMed ID: 17627537)
1. Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies.
Rusnati M; Presta M
Curr Pharm Des; 2007; 13(20):2025-44. PubMed ID: 17627537
[TBL] [Abstract][Full Text] [Related]
2. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
Ronca R; Giacomini A; Rusnati M; Presta M
Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factors, fibroblast growth factor receptors, diseases, and drugs.
Chen GJ; Forough R
Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):211-24. PubMed ID: 18221087
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
Presta M; Dell'Era P; Mitola S; Moroni E; Ronca R; Rusnati M
Cytokine Growth Factor Rev; 2005 Apr; 16(2):159-78. PubMed ID: 15863032
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications.
Cronauer MV; Schulz WA; Seifert HH; Ackermann R; Burchardt M
Eur Urol; 2003 Mar; 43(3):309-19. PubMed ID: 12600436
[TBL] [Abstract][Full Text] [Related]
6. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
[TBL] [Abstract][Full Text] [Related]
7. The role of fibroblast growth factors in tumor growth.
Korc M; Friesel RE
Curr Cancer Drug Targets; 2009 Aug; 9(5):639-51. PubMed ID: 19508171
[TBL] [Abstract][Full Text] [Related]
8. Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2.
Presta M; Foglio E; Churruca Schuind A; Ronca R
Front Immunol; 2018; 9():2327. PubMed ID: 30349543
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.
Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A
Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488
[TBL] [Abstract][Full Text] [Related]
10. Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.
Giacomini A; Chiodelli P; Matarazzo S; Rusnati M; Presta M; Ronca R
Pharmacol Res; 2016 May; 107():172-185. PubMed ID: 27013279
[TBL] [Abstract][Full Text] [Related]
11. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor inhibitors.
Kumar SB; Narasu L; Gundla R; Dayam R; J A R P S
Curr Pharm Des; 2013; 19(4):687-701. PubMed ID: 23016864
[TBL] [Abstract][Full Text] [Related]
13. The role of fibroblast growth factors in vascular development.
Javerzat S; Auguste P; Bikfalvi A
Trends Mol Med; 2002 Oct; 8(10):483-9. PubMed ID: 12383771
[TBL] [Abstract][Full Text] [Related]
14. Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction.
Plum SM; Vu HA; Mercer B; Fogler WE; Fortier AH
Immunopharmacol Immunotoxicol; 2004 Feb; 26(1):29-41. PubMed ID: 15106730
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factors and their inhibitors.
Botta M; Manetti F; Corelli F
Curr Pharm Des; 2000 Dec; 6(18):1897-924. PubMed ID: 11102567
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.
Hussain S; Slevin M; Matou S; Ahmed N; Choudhary MI; Ranjit R; West D; Gaffney J
Angiogenesis; 2008; 11(3):245-56. PubMed ID: 18330714
[TBL] [Abstract][Full Text] [Related]
17. FGF-2-mediated FGFR1 signaling in human microvascular endothelial cells is activated by vaccarin to promote angiogenesis.
Sun HJ; Cai WW; Gong LL; Wang X; Zhu XX; Wan MY; Wang PY; Qiu LY
Biomed Pharmacother; 2017 Nov; 95():144-152. PubMed ID: 28841454
[TBL] [Abstract][Full Text] [Related]
18. FGF receptor inhibitors: role in cancer therapy.
Daniele G; Corral J; Molife LR; de Bono JS
Curr Oncol Rep; 2012 Apr; 14(2):111-9. PubMed ID: 22311684
[TBL] [Abstract][Full Text] [Related]
19. FGFs and their receptors, in vitro and in vivo studies: new FGF receptor in the brain, FGF-1 in muscle, and the use of functional analogues of low-affinity heparin-binding growth factor receptors in tissue repair.
Soulet L; Chevet E; Lemaitre G; Blanquaert F; Meddahi A; Barritault D
Mol Reprod Dev; 1994 Sep; 39(1):49-54; discussion 54-5. PubMed ID: 7528027
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factors in cancer: therapeutic possibilities.
Jeffers M; LaRochelle WJ; Lichenstein HS
Expert Opin Ther Targets; 2002 Aug; 6(4):469-82. PubMed ID: 12223061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
